Skip to Content

Ansell Ltd ADR ANSLY

Morningstar Rating
$63.17 +0.32 (0.51%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ANSLY is trading at a 17% discount.
Price
$62.89
Fair Value
$86.32
Uncertainty
Medium
1-Star Price
$83.49
5-Star Price
$79.37
Economic Moat
Jsyvtz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANSLY is a good fit for your portfolio.

Trading Information

Previous Close Price
$62.85
Day Range
$62.5863.17
52-Week Range
$52.5975.95
Bid/Ask
$66.69 / $68.75
Market Cap
$1.97 Bil
Volume/Avg
6,009 / 1,314

Key Statistics

Price/Earnings (Normalized)
19.98
Price/Sales
1.25
Dividend Yield (Trailing)
2.68%
Dividend Yield (Forward)
2.68%
Total Yield
4.36%

Company Profile

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
46,758

Competitors

Valuation

Metric
ANSLY
CHD
RKT
Price/Earnings (Normalized)
19.9832.249.36
Price/Book Value
1.266.433.58
Price/Sales
1.254.302.08
Price/Cash Flow
9.1724.2611.26
Price/Earnings
ANSLY
CHD
RKT

Financial Strength

Metric
ANSLY
CHD
RKT
Quick Ratio
0.860.610.40
Current Ratio
2.111.080.64
Interest Coverage
7.379.729.00
Quick Ratio
ANSLY
CHD
RKT

Profitability

Metric
ANSLY
CHD
RKT
Return on Assets (Normalized)
4.13%9.58%8.60%
Return on Equity (Normalized)
6.66%21.40%26.61%
Return on Invested Capital (Normalized)
5.67%14.37%14.24%
Return on Assets
ANSLY
CHD
RKT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncJfrnwjjkyYpd$139.0 Bil
ALC
Alcon IncPbfnrhsrfZjpcsr$40.4 Bil
CLPBY
Coloplast A/S ADRJfrkzqftnVfnmw$29.9 Bil
WST
West Pharmaceutical Services IncKvlyvqrngSzct$28.5 Bil
RMD
ResMed IncZyhbdszxGwxwmf$28.5 Bil
BAX
Baxter International IncTxmbpzhfPfprzgl$21.4 Bil
COO
The Cooper Companies IncNhdnlchvnTcphzy$19.2 Bil
HOLX
Hologic IncZbtdqpdKtkpht$18.3 Bil
TFX
Teleflex IncLhpBwws$10.5 Bil
ATR
AptarGroup IncDqmzglnPdynjr$9.2 Bil

Sponsor Center